Insmed Retains FD and Gibraltar for Corporate Support
Charting the future of public relations
Holmes Report
CEO

Insmed Retains FD and Gibraltar for Corporate Support

Insmed, a biopharmaceutical company, has retained FD and Gibraltar Associates to provide investor relations and corporate communications services respectively.

Paul Holmes

RICHMOND, VA—Insmed, a biopharmaceutical company, has retained FD and Gibraltar Associates to provide investor relations and corporate communications services respectively. FD and Gibraltar will provide an integrated program to highlight Insmed’s role as a pioneer and leader in the emerging field of follow-on biologics and to increase the company’s institutional investor visibility.

“With the characterization of our first two follow-on biologics now completed and positioned for clinical studies, Insmed is at the forefront of a rapidly emerging field with significant growth potential,” said Geoffrey Allan, CEO. “We believe this is the right time to launch a comprehensive communications plan to identify high-quality institutional investors, and successfully position Insmed’s investment thesis.”

View Style:

Load 3 More
comments powered by Disqus